WOOJUNG BIO, Inc. (KOSDAQ:215380)

WOOJUNG BIO Statistics

Total Valuation

WOOJUNG BIO has a market cap or net worth of KRW 34.50 billion. The enterprise value is 82.96 billion.

Market Cap	34.50B
Enterprise Value	82.96B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

WOOJUNG BIO has 16.83 million shares outstanding. The number of shares has increased by 22.66% in one year.

Current Share Class	16.83M
Shares Outstanding	16.83M
Shares Change (YoY)	+22.66%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	33.61%
Owned by Institutions (%)	3.65%
Float	10.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.94
PB Ratio	1.37
P/TBV Ratio	1.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 32.06, with an EV/FCF ratio of -24.22.

EV / Earnings	-20.04
EV / Sales	2.27
EV / EBITDA	32.06
EV / EBIT	n/a
EV / FCF	-24.22

Financial Position

The company has a current ratio of 0.56, with a Debt / Equity ratio of 2.06.

Current Ratio	0.56
Quick Ratio	0.21
Debt / Equity	2.06
Debt / EBITDA	20.06
Debt / FCF	-15.17
Interest Coverage	-0.46

Financial Efficiency

Return on equity (ROE) is -16.34% and return on invested capital (ROIC) is -1.13%.

Return on Equity (ROE)	-16.34%
Return on Assets (ROA)	-0.95%
Return on Invested Capital (ROIC)	-1.13%
Return on Capital Employed (ROCE)	-2.35%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.40
Inventory Turnover	4.39

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.63% in the last 52 weeks. The beta is 0.47, so WOOJUNG BIO's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	-5.63%
50-Day Moving Average	1,744.34
200-Day Moving Average	1,676.91
Relative Strength Index (RSI)	74.78
Average Volume (20 Days)	1,614,571

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WOOJUNG BIO had revenue of KRW 36.60 billion and -4.14 billion in losses. Loss per share was -308.29.

Revenue	36.60B
Gross Profit	10.81B
Operating Income	-1.38B
Pretax Income	-4.14B
Net Income	-4.14B
EBITDA	2.59B
EBIT	-1.38B
Loss Per Share	-308.29

Balance Sheet

The company has 3.51 billion in cash and 51.96 billion in debt, giving a net cash position of -48.45 billion or -2,879.14 per share.

Cash & Cash Equivalents	3.51B
Total Debt	51.96B
Net Cash	-48.45B
Net Cash Per Share	-2,879.14
Equity (Book Value)	25.19B
Book Value Per Share	1,511.20
Working Capital	-14.18B

Cash Flow

In the last 12 months, operating cash flow was -2.87 billion and capital expenditures -552.97 million, giving a free cash flow of -3.42 billion.

Operating Cash Flow	-2.87B
Capital Expenditures	-552.97M
Free Cash Flow	-3.42B
FCF Per Share	-203.48

Margins

Gross margin is 29.54%, with operating and profit margins of -3.77% and -11.31%.

Gross Margin	29.54%
Operating Margin	-3.77%
Pretax Margin	-11.31%
Profit Margin	-11.31%
EBITDA Margin	7.08%
EBIT Margin	-3.77%
FCF Margin	n/a

Dividends & Yields

WOOJUNG BIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.66%
Shareholder Yield	-22.66%
Earnings Yield	-12.00%
FCF Yield	-9.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 30, 2019. It was a forward split with a ratio of 2.

Last Split Date	Jul 30, 2019
Split Type	Forward
Split Ratio	2

Scores

WOOJUNG BIO has an Altman Z-Score of -0.02 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.02
Piotroski F-Score	3